Renaissance Technologies’s Titan Medical Inc. Ordinary Shares TMDI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-38,500
Closed -$20K 4539
2022
Q2
$20K Sell
38,500
-87,147
-69% -$42.6K ﹤0.01% 4122
2022
Q1
$66K Sell
125,647
-141,184
-53% -$81.9K ﹤0.01% 3862
2021
Q4
$167K Buy
266,831
+181,046
+211% +$204K ﹤0.01% 3574
2021
Q3
$130K Sell
85,785
-262,430
-75% -$426K ﹤0.01% 3280
2021
Q2
$595K Sell
348,215
-741,768
-68% -$1.28M ﹤0.01% 2894
2021
Q1
$1.85M Buy
1,089,983
+500,783
+85% +$1.12M ﹤0.01% 2281
2020
Q4
$1.01M Buy
+589,200
New +$585K ﹤0.01% 2491
2020
Q3
Sell
-34,645
Closed -$29K 3794
2020
Q2
$29K Sell
34,645
-258,655
-88% -$132K ﹤0.01% 3366
2020
Q1
$79K Buy
293,300
+204,800
+231% +$81.6K ﹤0.01% 3266
2019
Q4
$44K Buy
+88,500
New +$54.3K ﹤0.01% 3399

Other funds holding TMDI

Renaissance Technologies's TMDI Position: Q3 2022 in Review

Renaissance Technologies sold out of Titan Medical Inc. Ordinary Shares (TMDI) in Q3 2022, closing a stake of 38,500 shares — an estimated $20K sold.

Renaissance Technologies first reported a position in TMDI in Q4 2019 and held it in 10 quarters. The position peaked at $1.85M in Q1 2021. 55 funds tracked by Wall St. Rank hold TMDI as of Q3 2022.

  • Renaissance Technologies reported no remaining Titan Medical Inc. Ordinary Shares position as of Q3 2022 after selling out during the quarter.
  • Renaissance Technologies sold 38,500 Titan Medical Inc. Ordinary Shares shares in Q3 2022, an estimated $20K.
  • Renaissance Technologies first reported a position in Titan Medical Inc. Ordinary Shares in Q4 2019 and held it in 10 quarters.
  • Renaissance Technologies's Titan Medical Inc. Ordinary Shares position peaked at $1.85M in Q1 2021.
  • 55 funds tracked by Wall St. Rank held Titan Medical Inc. Ordinary Shares as of Q3 2022.

Based on Renaissance Technologies's 13F filing for Q3 2022, filed 14 Nov 2022.